OIG Insight on Genetic Testing for Health Care Industries

OIG advisory ppinion on provision of free genetic testing and counseling services by a pharmaceutical manufacturer would not result in the imposition of sanctions under the federal Anti-Kickback Statute AKS and the beneficiary inducements civil monetary penalty provision

Related Keywords

,Counseling Vendor For Services ,Department Of Health ,Office Of Inspector ,Human Services ,Counseling Services ,Inspector General ,Advisory Opinion ,Anti Kickback Statute ,Beneficiary Inducements ,Gene Mutations ,Genetic Test ,Eligible Patients ,Testing Vendor ,Genetic Tests ,Counseling Vendor ,Inappropriate Utilization ,Gene Mutation ,Decision Making ,Patient Safety ,Care Quality ,Legal ,Government ,Business ,Twig ,Tks ,Ffice Of Inspector General For The Department Health And Human Services ,Genetic Testing ,Ivil Monetary Penalty Provision ,